FDA Approves Treatment for Moderate-to-Severe Chronic Hand Eczema
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
The device uses 2.45-GHz energy and three handpieces designed to target subcutaneous tissue while maintaining surface cooling, according to the company.